CHEMED CORP·4

Oct 23, 3:13 PM ET

Witzeman Michael D 4

4 · CHEMED CORP · Filed Oct 23, 2024

Insider Transaction Report

Form 4
Period: 2024-10-22
Witzeman Michael D
VP & Chief Financial Officer
Transactions
  • Award

    Stock Option (right to buy with tandem tax withholding)

    2024-10-22$597.70/sh+13,395$8,006,19243,280 total
    Exercise: $597.70Exp: 2029-10-22Capital Stock (13,395 underlying)
Footnotes (1)
  • [F1]Vesting in three equal annual installments commencing 10/22/2025

Documents

1 file
  • 4
    ownership.xmlPrimary

    4